CLPT Clearpoint Neuro Inc
Company Analysis
Latest News
🔴 Clearpoint Neuro is trading 6% down in pre-market after revenue miss and reduced 2026 outlook
Clearpoint Neuro is trading 6.03% down at $10.05 after a revenue miss and reduced 2026 outlook. - October 28 results: revenue was $12.1 million versus $12.5...
🟢 Clearpoint Neuro is trading 5.5% up today after Q3 revenue rose 36% year over year
Clearpoint Neuro is trading at $11.14, up 5.49%, after reporting Q3 revenue of $12.1 million, up 36% year over year. - Neurosurgery navigation and therapy...
ClearPoint Neuro third quarter 2026 revenue rises 36% as loss per share beats estimates
ClearPoint Neuro reported third quarter 2026 revenue of $12.1 million, a 36% year-over-year increase, narrowly missing analyst estimates of $12.3 million. The...
🟢 Clearpoint Neuro is trading 10% up with no confirmed company-specific catalyst
Clearpoint Neuro is trading 10.11% up at $10.67; available reporting has not identified a confirmed company-specific catalyst. - Third-quarter results are...
🟢 Clearpoint Neuro is trading 5% up with no confirmed catalyst
Clearpoint Neuro is trading at $10.18, up 5.01%, with no confirmed catalyst identified for the October 28 move. - The company is scheduled to report...
🟢 Clearpoint Neuro is trading 5% up
Clearpoint Neuro is trading at $9.52, up 5.25%, with no company-specific announcement identified to explain the October 27 move. - The Nasdaq rose 0.96% and...
Clearpoint Neuro Inc Q3 2026 Earnings Preview: What Analysts Expect on October 28, 2026
Clearpoint Neuro is expected to report Q3 2026 revenue of $12.30 million and an EPS loss of $0.32, with the stock currently trading at $9.14 compared to an...
🔴 Clearpoint Neuro is trading 10.05% down in pre-market — with no confirmed company explanation
Clearpoint Neuro is trading at $8.50, down 10.05% in pre-market; no confirmed company announcement directly explains the decline. - Investor-law-firm notices...
🟢 Clearpoint Neuro is trading 5% up today as healthcare-sector strength may support shares
Clearpoint Neuro is trading 5.34% up now at $9.66, with healthcare-sector strength and rotation away from technology stocks potentially supporting the...
🟢 Clearpoint Neuro is trading 7% up in pre-market
Clearpoint Neuro is trading at $9.79, up 6.76% versus the October 19 close, with no clear company-specific catalyst identified for the pre-market gain. - The...
🔴 Clearpoint Neuro is trading 8% down in pre-market
Clearpoint Neuro is trading at $8.43, down 8.04%, with no clear company-specific catalyst identified for the October 20 pre-market decline. - The company’s...
🔴 Clearpoint Neuro is trading 9.6% down in pre-market
Clearpoint Neuro is trading 9.6% down at $8.20 in pre-market, with no company-specific announcement identified to explain the decline. - The latest company...
🔴 Clearpoint Neuro is trading 6.1% down as cause remains unclear
Clearpoint Neuro is trading 6.1% lower at $9.05, and the cause of the decline remains unclear. - No company-specific announcement explaining the decline was...
🔴 Clearpoint Neuro is trading 5.5% down in after-hours trading
Clearpoint Neuro is trading 5.5% down at $9.11 in after-hours trading, and the reason for the decline remains unclear. - Shares closed at $9.64 in the October...
🔴 Clearpoint Neuro is trading 5% down today amid likely CPI-driven market pressure
Clearpoint Neuro is trading at $9.31, down 5.1%, with CPI-driven market pressure the most likely explanation. - No new company-specific announcement was...
🔴 Clearpoint Neuro is trading 5% down
Clearpoint Neuro is trading 5.25% down at $10.91, with no new company announcement explaining the October 6 decline. - The latest listed release was its...
🟢 Clearpoint Neuro is trading 5% up today amid broader market gains
Clearpoint Neuro is trading at $11.45, up 5.09%, with broader risk-on sentiment the likeliest context; no company-specific catalyst was identified. - U.S....
🟢 Clearpoint Neuro is trading 5% up in pre-market
Clearpoint Neuro is trading 5.28% up at $11.47 in pre-market on October 5, 2026, with no new company-specific announcement identified to explain the move. -...
🔴 Clearpoint Neuro is trading 5% down amid possible healthcare-sector pressure
Clearpoint Neuro is trading at $11.59, down 5.08% on October 1, 2026; no new company-specific announcement explaining the decline surfaced in the search. -...
🟢 Clearpoint Neuro is trading 6% up on September 30, 2026 with no identified catalyst
Clearpoint Neuro is trading at $12.42, up +5.53% during the September 30 session, with no specific catalyst identified. - No new Clearpoint Neuro announcement...